The Journal of Organic Chemistry
Article
cyclic tetramer 6 agree with previously published data.17 A 14 mg
amount of 8 (21%) was obtained during this experiment.
REFERENCES
■
(1) Greenberg, A.; Breneman, C. M.; Liebman, J. F., Eds. The Amide
Linkage: Structural Significance in Chemistry, Biochemistry and Materials
Science; Wiley: New York, 1999.
(2) Davidson, B. S. Chem. Rev. 1993, 93, 1771−1791.
(3) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. J. Org.
Biomol. Chem. 2006, 4, 2337−2347.
(4) Hamamoto, Y.; Endo, M.; Nakagawa, T.; Nakanishi, T.;
Mizukawa, K. J. Chem. Soc., Chem. Commun. 1983, 323−324.
(5) Caba, J. M.; Rodriguez, I. M.; Manzanares, I.; Giralt, E.; Albericio,
F. J. Org. Chem. 2001, 66, 7568−7574.
(6) Pattenden, G.; Thompson, T. Chem. Commun. 2001, 717−718.
(7) Hamada, Y.; Kato, S.; Shioiri, T. Tetrahedron Lett. 1985, 26,
3223−3226.
(8) Degnan, B. M.; Hawkins, C. J.; Lavin, M. F.; McCaffrey, E. J.;
Parry, D. L.; Van den Brenk, A. L.; Watters, D. J. J. Med. Chem. 1989,
32, 1349−1354.
(9) Michael, J. P.; Pattenden, G. Angew. Chem., Int. Ed. Engl. 1993, 32,
1−23.
(10) Gewald, K.; Schinke, E.; Bottcher, H. Chem. Ber. 1966, 99, 94−
Cyclic Octamer 8. A solution of tetramer 4d (50 mg, 0.051 mmol),
T3P (32 mg, 0.10 mmol), and Et3N (14 μL) in CH2Cl2 (200 mL) was
activated in the ultrasound bath at rt for 2 h. The crude solution was
washed with water and brine. After drying the organic layer with
Na2SO4, the solvent was evaporated under reduced pressure. Pure
macrocycle 8 (25 mg, 50%) was obtained as a yellow solid after
purification by column chromatography (silica gel, eluent 4:1 EtOAc/
hexane). Mp 190−195 °C; HRMS (ESI+) calcd for
C88H104N8O24S8Na 1935.4821; found 1935.4806; 1H NMR (250
MHz, CDCl3, 25 °C, TMS): δ = 11.22 (s, 8H, NH); 7.05 (s, 8H,
thioph); 3.83 (s, 16H, CH2), 1.47 (s, 72H, t-Bu); 13C NMR (176
MHz, CDCl3, 25 °C, TMS): δ = 166.6, 164.9 (CON); 147.7 (SCN);
124.7 (SCCH2); 124.3 (CHthioph); 115.0, 110.14 (CCO2t-Bu); 82.0 (t-
Bu); 42.0 (CH2); 28.4 (t-Bu). A 18 mg amount of 6 (37%) was
obtained during this experiment.
Cyclic Hexamer 7. To an activated solution of Et3N (19 μL, 0.135
mmol) in CH2Cl2 (70 mL) in an ultrasound bath was added dropwise,
over 2 h, a mixture of linear tetramer 3d (50 mg, 0.068 mmol) and
T3P (43 mg, 0.135 mmol). The solution was sonificated for additional
2 h. The crude solution was washed with water and brine. After drying
the organic layer with Na2SO4, the solvent was evaporated under
reduced pressure. Pure macrocycle 7 (16 mg, 33%) was obtained as a
yellow solid after purification by column chromatography (silica gel,
eluent 1% MeOH in CH2Cl2). The spectroscopic and physical
properties of cyclic tetramer 7 agree with previously published data.17
A 3 mg amount of 9 (6%) was obtained during this experiment. Two
different solvent systems were employed to obtain crystals from 7,
namely by slow diffusion of hexane into the solution of 7 in CH2Cl2
and by slow evaporation of 1,2-dichloroethane as solvent.
Cyclic Nonamer 9. A solution of tetramer 3d (100 mg, 0.136
mmol), T3P (87 mg, 0.273 mmol), and Et3N (38 μL, 0.273 mmol) in
CH2Cl2 (5 mL) was activated in the ultrasound bath at rt for 1 h. The
crude solution was washed with water and brine. After drying the
organic layer with Na2SO4, the solvent was evaporated under reduced
pressure. Pure macrocycle 9 (31 mg, 32%) was obtained as an orange-
red solid after purification by column chromatography (silica gel,
eluent 4:1 EtOAc/hexane). Mp 135−137 °C; HRMS (ESI+) calcd for
C99H117N9O27S9Na 2175.5477; found 2175.5482; 1H NMR (250
MHz, CDCl3, 25 °C, TMS): δ = 11.22 (s, 9H, NH); 7.06 (s, 9H,
thioph); 3.83 (s, 18H, CH2); 1.49 (s, 81H, t-Bu); 13C NMR (176
MHz, CDCl3, 25 °C, TMS): δ = 166.6, 164.9 (CON); 147.7 (SCN);
124.7 (SCCH2); 124.3 (CHthioph); 115.0, 110.14 (CCO2t-Bu); 82.0 (t-
Bu); 37.0 (CH2); 28.4 (t-Bu). A 25 mg amount of 7 (26%) was
obtained during this experiment.
̈
100.
(11) Sabnis, R. W.; Rangnekar, D. W.; Sonawane, N. D. J. Heterocycl.
Chem. 1999, 36, 333−345.
(12) Fu, T. L.; Wang, I. Dyes Pigm. 2008, 76, 590−595.
(13) Huang, Y.; Doemling, A. Mol. Divers. 2011, 15, 3−33.
(14) Tormyshev, V. M.; Trukhin, D. V.; Rogozhnikova, O. Y.;
Mikhalina, T. V.; Troitskaya, T. I.; Flinn, A. Synlett 2006, 2559−2564.
(15) Puterova,
́
Z.; Krutoskikova, A.; Vegh, D. ARKIVOC 2010, i,
209−246.
̈
(16) Ozbek, H.; Veljkovic, I. S.; Reissig, H.-U. Synlett 2008, 3145−
3148.
̈
(17) Ozbek, H.; Lentz, D.; Reissig, H.-U. Eur. J. Org. Chem. 2010,
6319−6322.
(18) Reichelt, I.; Reissig, H.-U. Synthesis 1984, 786−787.
(19) Grimm, E. L.; Reissig, H.-U. J. Org. Chem. 1985, 50, 242−244.
(20) Grimm, E. L.; Zschiesche, R.; Reissig, H.-U. J. Org. Chem. 1985,
50, 5543−5545.
(21) Ullmann, A.; Schnaubelt, J.; Reissig, H.-U. Synthesis 1998,
1052−1066.
(22) Zimmer, R.; Ziemer, A.; Gruner, M.; Brudgam, I.; Hartl, H.;
̈
Reissig, H.-U. Synthesis 2001, 1649−1658.
(23) Patra, P. K.; Reissig, H.-U. Eur. J. Org. Chem. 2001, 4195−4206.
(24) Veljkovic, I.; Zimmer, R.; Reissig, H.-U.; Brudgam, I.; Hartl, H.
̈
Synthesis 2006, 2677−2684.
(25) Reissig, H.-U. Top. Curr. Chem. 1988, 144, 73−135.
(26) Reissig, H.-U.; Zimmer, R. Chem. Rev. 2003, 103, 1151−1196.
(27) Gnad, F.; Reiser, O. Chem. Rev. 2003, 103, 1603−1624.
(28) Yu, M.; Pagenkopf, B. L. Tetrahedron 2005, 61, 321−347.
(29) De Simone, F.; Waser, J. Synthesis 2009, 3353−3374.
(30) Carson, C. A.; Kerr, M. A. Chem. Soc. Rev. 2009, 38, 3051−3060.
(31) Schneider, T. F.; Werz, D. B. Org. Lett. 2011, 13, 1848−1851.
(32) Campbell, J.; Johnson, J. S.; Parsons, A. T.; Pohlhaus, P. D.;
Sanders, S. D. J. Org. Chem. 2010, 75, 6317−6325.
(33) Schneider, T. F.; Kaschel, J.; Awan, S. I.; Dittrich, B.; Werz, D.
B. Chem.Eur. J. 2010, 16, 11276−11288.
ASSOCIATED CONTENT
■
S
* Supporting Information
Crystallographic data of macrocycle 7 and H and 13C NMR
1
spectra of new compounds 3b, 5, 8, and 9. This material is
AUTHOR INFORMATION
Corresponding Author
■
(34) Lebold, T. P.; Kerr, M. A. Pure Appl. Chem. 2010, 82, 1797−
1812.
Notes
(35) Mel’nikov, M. Y.; Budynina, E. M.; Ivanova, O. A.; Trushkov, I.
The authors declare no competing financial interest.
V. Mendeleev Commun. 2011, 21, 293−301.
(36) Goschke, R.; Stutz, S.; Rasetti, V.; Cohen, N.-C; Rahuel, J.;
̈
ACKNOWLEDGMENTS
Rigollier, P.; Baum, H.-P.; Forgiarini, P.; Schnell, C. R.; Wagner, T.;
Gruetter, M. G.; Fuhrer, W.; Schilling, W.; Cumin, F.; Wood, J. M.;
Maibaum, J. J. Med. Chem. 2007, 50, 4818−4831.
■
The authors thank the Alexander von Humboldt Foundation
for a postdoctoral fellowship for T. H. Ngo, and Bayer
HealthCare for generous support. We gratefully acknowledge
support of H. Berndt by the Deutsche Forschungsgemeinschaft
(GKR 788). We also thank Dr. U. K. Wefelscheid for making us
familiar with T3P, and Archimica GmbH for providing this
crucial reagent.
(37) Jamieson, A. G.; Russell, D.; Hamilton, A. D. Chem. Commun.
2012, 48, 3709−3711.
(38) Qian, Y.; Marugan, J. J.; Fossum, R. D.; Vogt, A.; Sebti, S. M.;
Hamilton, A. D. Bioorg. Med. Chem. 1999, 7, 3011−3024.
(39) Sakowski, J.; Bohm, M.; Sattler, I.; Dahse, H.-M.; Schlitzer, M. J.
̈
Med. Chem. 2001, 44, 2886−2899.
9682
dx.doi.org/10.1021/jo3017605 | J. Org. Chem. 2012, 77, 9676−9683